Skip to content

Astra strikes $1 billion gene therapy deal with Pfizer

The agreement with Pfizer is worth up to $1 billion plus tiered royalties on sales after that, the company said Friday. The transaction is due to complete in the third quarter.

Read More

​ The agreement with Pfizer is worth up to $1 billion plus tiered royalties on sales after that, the company said Friday. The transaction is due to complete in the third quarter. The agreement with Pfizer is worth up to $1 billion plus tiered royalties on sales after that, the company said Friday. The transaction is due to complete in the third quarter.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish